ABVC BIOPHARMA INC (ABVC) Stock Income Statement
NASDAQ:ABVC - Nasdaq - US00091F3047 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 508.40K | 509.60K | 152.40K | 970.00K | 360.00K | |||
| Minority Interest Expense | 410.20K | 356.20K | 492.80K | -110.00K | -800.00K | |||
| Cost Of Goods | 500.00 | 800.00 | 302.00K | 290.00K | 10.00K | |||
| Gross Profit | 508.00K | 508.80K | -149.60K | 680.00K | 350.00K | |||
| Operating Expenses | 2.46M | 5.21M | 6.62M | 15.79M | 12.05M | |||
| Research and Development | 139.10K | 179.30K | 1.06M | 2.69M | 1.00M | |||
| Selling, General, and Administrative Expenses | 2.32M | 5.03M | 5.55M | 13.10M | 11.05M | |||
| Operating Income | -1.95M | -4.71M | -6.77M | -15.11M | -11.71M | |||
| Interest Income/Expense | -800.40K | -1.10M | -1.33M | -370.00K | -30.00K | |||
| Other Income/Expense | 166.00K | 182.90K | 69.30K | 80.00K | 520.00K | |||
| Non Recurring Items | N/A | 255.60K | 0.00 | -110.00K | 0.00 | |||
| Income Before Taxes | -2.33M | -5.37M | -8.02M | -15.51M | -11.21M | |||
| Income Tax | -110.50K | -110.50K | 256.00K | 800.00K | 830.00K | |||
| Net Income | -1.81M | -4.90M | -7.79M | -16.42M | -12.84M | |||
| EBITDA | -1.92M | -4.67M | -6.74M | -15.09M | -11.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.14 | -0.42 | -1.80 | -5.19 | -5.12 | |||
| Statistics | ||||||||
| Gross Profit Margin | 99.92% | 99.84% | -98.16% | 70.10% | 97.22% | |||
| Profit Margin | -356.43% | -962.11% | -5110.30% | -1692.78% | -3566.67% | |||
| Operating Profit Margin | -384.30% | -923.31% | -4440.09% | -1557.73% | -3252.78% | |||
All data in USD